Implementation of the newborn screening programme for sickle cell disease in England: Results for 2003-2005

Journal of Medical Screening

Volumn 15, Issue 1, 2008, Pages 9-13

  Streetly, Allison ^a   Clarke, Mary ^b   Downing, Melanie ^c   Farrar, Lisa ^d   Foo, Ying ^e   Hall, Kate ^f   Kemp, Helena ^g   Newbold, Jane ^h   Walsh, Paul ⁱ   Yates, Jenny ^j   Henthorn, Joan ^k  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST HELIER HOSPITAL   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^e Newborn Screening Laboratory   (United Kingdom)

^f BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^g SOUTHMEAD HOSPITAL   (United Kingdom)

^h KING S COLLEGE HOSPITAL   (United Kingdom)

ⁱ ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^j ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^k CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN VARIANT;

ARTICLE; BETA THALASSEMIA; BLOOD ANALYSIS; COUNSELING; ETHNICITY; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; PERFORMANCE; PREVALENCE; QUALITY CONTROL; SICKLE CELL ANEMIA; STANDARD; UNITED KINGDOM;

ANEMIA, SICKLE CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENGLAND; HEMOGLOBIN, SICKLE; HUMANS; INFANT, NEWBORN; ISOELECTRIC FOCUSING; NEONATAL SCREENING;

EID: 43049118626     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2008.007063     Document Type: Article

References (20)

1. Weatherall D, Akinyanju O, Fucharoen S, Oliveri N, Musgrove P. 'Inherited disorders of haemoglobin.' In: Jamison DT, Bremen JG, Measham AR, Alleyne G, Claeson M, eds. Disease Control Priorities in Developing Countries, 2nd edn. New York: Oxford University Press, 2006:663-80. DOI: 10.1596/978-0-821- 36179-5/Chpt-34. See [http://www.dcp2.org/pubs/DCP]
2. Christianson A, Howson CP, Modell B. The March of Dimes Global Report on Birth Defects. The Hidden Toll of Dying and Disabled Children. White Plains, New York: March of Dimes Birth Defects Foundation, 2006. See [http://mod.hoggmsnpt.com/MOD-Report.pdf] (last accessed September 2006)
3. World Health Organisation. Sickle-cell Anaemia: Report by the Secretariat, 2006. See [http://www.who.int/gb/ebwha/pdf_files/WHA59/A59_9- en.pdf] (last accessed October 2006)
4. London Health Observatory. Analysis of Frequent Users, 2002/03, Local Authority Level, 2005. See [http://www.lho.org.uk/viewResource.aspx?id=9736] (last accessed September 2006)
5. London Health Observatory. Analysis of Frequent Hospital Users, by PCT 2003/4, 2006. See [http://www.lho.org.uk/viewResource.aspx?id=10286] (last accessed September 2006)
6. Zeuner D, Ades AE, Karnon J, Brown J, Dezateux C, Anionwu EN. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess 1999;4:117-121. See [http://www.hta.ac. uk/project.asp?PjtId=915] (last accessed September 2006)
7. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. Health Technol Assess 2000;4:67-68 (last accessed September 2006). See http://www.hta.ac.uk/project.asp?PjtId=916
8. Department of Health. The NHS Plan:a Plan for Investment, a Plan for Reform, 2000. See [http://www.nhsia.nhs.uk/nhsplan/nhsplan.htm] (last accessed September 2006)
9. NHS Haemoglobinopathy Screening Programme. International Workshop on Haemoglobinopathy Screening to inform the screening developments in England, 2001. See [http://www.sickleandthal.org.uk/dowloads/ International%20%20Workshop%20Report.pdf] (last accessed January 2007)
10. Harris MS, Eckman JR. Georgia's experience with newborn screening: 1981-1985. Pediatrics 1989;83:858-60
11. Sassi F, Le Grand J, Archard L. Equity versus efficiency: a dilemma for the NHS. BMJ 2001;323:762-3.ref from BMJ
12. NHS Sickle Cell and Thalassaemia Screening Programme (November 2006). Standards for the linked Antenatal and Newborn Screening Programme. See [http://www.sickleandthal.org.uk/publications. htm#ProgStandards]
13. Dick M, Annie K, Darbyshire P, Howard J, Rees D, Smalling B, Tefler P, Welch J. UK forum on Haemoglobin Disorders. Sickle Cell Disease in Childhood: Standards and Guidelines for Clinical Care. NHS Sickle Cell and Thalassaemia Screening Programme, 2006. See [http://www.sickleandthal.org.uk/ publications.htm#ClinicalCareGuidelines]
14. NHS Sickle Cell and Thalassaemia Screening Programme Handbook for Laboratories. See [http://www.sickleandthal.org.uk/publications. htm#LabHandbook] (last accessed September 2006)
15. Davis H, Gergen PJ, Moore RM Jr. Geographic differences in mortality of young children with sickle cell disease in the United States. Public Health Rep 1997;112:52-8
16. Milne RI. Assessment of care of children with sickle cell disease: implications for neonatal screening programmes. BMJ 1990;300:371-4
17. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ 1995;311:1600-2
18. National Screening Committee. Appendix C: The UK National Screening Committee Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. In: Second report of the UK National Screening Committee, Department of Health, 26-27, 1999. See [http://www.nsc.nhs.uk/pdfs/secondreport.pdf] (last accessed 19 February 2008)
19. Streetly A, Grant C, Bickler G, Eldridge P, Bird S, Griffiths W. The Metabolic ('Guthrie') Neonatal screening programme: variation in coverage by ethnic group: possible explanations and implications. BMJ 1994;309:372-4
20. Modell B, Darlinson M, Birgens H, et al. Epidemiology of haemaglobin disorders in Europe: an overview. Scand J Clin Lab Invest 2007;67:39-70